Up Health, Inc. UPH-WT
We take great care to ensure that the data presented and summarized in this overview for UpHealth, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in UPH-WT
Top Purchases
Top Sells
About UPH-WT
Insider Transactions at UPH-WT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.35%
|
$0
$0.35 P/Share
|
|
May 22
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
699
-1.56%
|
$0
$0.48 P/Share
|
|
May 22
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.33%
|
$0
$0.48 P/Share
|
|
May 21
2024
|
Agnes Rey Giraud |
SELL
Open market or private sale
|
Direct |
13,282
-5.83%
|
$0
$0.61 P/Share
|
|
Apr 11
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,658
-7.54%
|
$3,658
$1.04 P/Share
|
|
Apr 11
2024
|
Martin S A Beck Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,340
+20.28%
|
-
|
|
Apr 11
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-1.93%
|
$522
$1.04 P/Share
|
|
Apr 11
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+4.93%
|
-
|
|
Mar 07
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-2.51%
|
$0
$0.7 P/Share
|
|
Mar 07
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-1.58%
|
$0
$0.7 P/Share
|
|
Jan 31
2024
|
Avi S Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.75%
|
-
|
|
Jan 31
2024
|
Mariya Pylypiv Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+11.16%
|
-
|
|
Jan 31
2024
|
Raluca Dinu Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.75%
|
-
|
|
Jan 31
2024
|
Mark Guinan Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+38.37%
|
-
|
|
Jan 31
2024
|
Luis Machuca Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+38.37%
|
-
|
|
Jan 31
2024
|
Agnes Rey Giraud |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.64%
|
-
|
|
Jan 31
2024
|
Chirinjeev Kathuria Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+2.47%
|
-
|
|
Jan 31
2024
|
James S Greene Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Nov 27
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-1.85%
|
$0
$0.61 P/Share
|
|
Nov 21
2023
|
Avi S Katz Director |
SELL
Open market or private sale
|
Direct |
280
-1.98%
|
$0
$0.4 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
352
Shares
From
1
Insiders
| Payment of exercise price or tax liability | 352 shares |
|---|